Autopsy report · NCT00804310
Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 years 1 month before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- University of California, Davis
- Sponsor type
- University, hospital or other
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- ixabepilone; lapatinib ditosylate
- Participants
- 5
- Sites
- 4
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.